About ALNY Dividend Returns
Alnylam Pharmaceuticals, Inc. (ALNY) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of ALNY over the past year?
Alnylam Pharmaceuticals, Inc. (ALNY) delivered a return of 34.92% over the past year. Since ALNY does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in ALNY be worth today?
A $10,000 investment in Alnylam Pharmaceuticals, Inc. one year ago would be worth $13,492 today, representing a gain of $3,492.
Q3Does ALNY pay dividends?
Alnylam Pharmaceuticals, Inc. (ALNY) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ALNY, the total return equals the price-only return.
Q4Did ALNY beat the S&P 500?
Yes, Alnylam Pharmaceuticals, Inc. (ALNY) outperformed the S&P 500 by 19.47 percentage points over the past year. ALNY delivered a total return of 34.92%, compared to the S&P 500's 15.45%. This 19.47pp alpha means investors in ALNY earned more than a passive S&P 500 index fund.
Q5What is ALNY's worst drawdown?
Alnylam Pharmaceuticals, Inc. (ALNY) experienced a maximum drawdown of -37.20% over the past year, declining from its peak on 2025-10-20 to its trough on 2026-02-12. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is ALNY's long-term total return over 10, 20, or 30 years?
Alnylam Pharmaceuticals, Inc. (ALNY) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 468.4% (19.0% CAGR) — $10,000 would have grown to $56,841. Over 20 years: 1970.4% total return (16.4% CAGR) — $10,000 → $207,039. Over 30 years: 5439.4% total return (14.3% CAGR) — $10,000 → $553,938. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was ALNY's best and worst year?
Alnylam Pharmaceuticals, Inc.'s best calendar year was 2013 with a total return of 235.4%. Its worst year was 2016 with a total return of -59.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 295.2 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).